Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Planning for retirement at 50 involves several key considerations. Being informed can help ensure a successful transition.
18,889 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Measles poses a bigger public health risk than Ebola as the World Cup attracts millions to U.S. host cities. Official...
An out-of-state investor faces a flood at the final walkthrough. This article unveils how savvy loans, careful due di...
Nearly 40% of Stanford undergraduates are registered with disability services, a surge linked to broader Gen Z trends...
A family with a calling aims to relocate to Caracas to fund $10,000 monthly aid. This report breaks down the costs, c...
A high-profile wedding can feel overwhelming, but a simple personal message can change how guests perceive the event—...
A Worthington Steel board director recently sold 2,500 shares as the company pursues a major acquisition. Learn what ...
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...
As Verastem prepares for its 2025 earnings outlook, investors should focus on cash runway, collaboration milestones, ...
As UNFI approaches its 2026 earnings call, investors want clarity on margins, growth drivers, and capital strategy. T...
Pinterest stock has faced headwinds, but a longer horizon reveals a compelling setup. Here are three solid reasons re...
SpaceX IPO chatter has investors buzzing about windfalls for insiders and thousands of workers with equity. This repo...